Search

Search Constraints

You searched for: Author/Creator Heymans, Stephane

Search Results

21. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. (7th April 2021)

22. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. (7th April 2021)

24. Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trial. (6th September 2022)

25. Early identification of patients with Chagas disease at risk of developing cardiomyopathy using 2-D speckle tracking strain: Win, Miranda prediction of Chagas cardiomyopathy. (August 2022)

26. Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial. (16th January 2020)

27. Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure). (17th February 2020)

28. ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models. (23rd February 2014)

30. Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy. Issue 15 (26th September 2022)